Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz-Josef Neumann

Showing results (351-360 of 477) with videos related to

Pageof 48
Sort By:
Circulation|May 22, 2002
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET TrialGregg W Stone, David J Moliterno, Michel Bertrand, et al.
American Heart Journal|September 3, 2011
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapyWillibald Hochholzer, Dietmar Trenk, Jessica L Mega, et al.
European Heart Journal|May 19, 2016
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trialMichael Haude, Hüseyin Ince, Alexandre Abizaid, et al.
JACC. Cardiovascular Interventions|October 9, 2020
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes MellitusGjin Ndrepepa, Adnan Kastrati, Maurizio Menichelli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 14, 2011
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registryFlorim Cuculi, Adrian P Banning, Alexander Abizaid, et al.
JACC. Cardiovascular Interventions|October 25, 2014
Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot studyJosep Rodés-Cabau, Philip Kahlert, Franz-Josef Neumann, et al.
Coronary Artery Disease|February 1, 2022
Prediction of risk for bleeding, myocardial infarction and mortality after percutaneous coronary intervention in patients with acute coronary syndromesGjin Ndrepepa, Franz-Josef Neumann, Maurizio Menichelli, et al.
Journal of the American College of Cardiology|May 5, 2018
Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft LesionsRoisin Colleran, Sebastian Kufner, Julinda Mehilli, et al.
Circulation Research|June 23, 2018
The Transcription Factor ETV1 Induces Atrial Remodeling and ArrhythmiaCarolin Rommel, Stephan Rösner, Achim Lother, et al.
Journal of the American College of Cardiology|October 18, 2003
A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein graftsVolker Schächinger, Christian W Hamm, Thomas Münzel, et al.
Pageof 48

Showing results (351-360 of 477) with videos related to

Sort By:
Pageof 48
Circulation|May 22, 2002
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET TrialGregg W Stone, David J Moliterno, Michel Bertrand, et al.
American Heart Journal|September 3, 2011
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapyWillibald Hochholzer, Dietmar Trenk, Jessica L Mega, et al.
European Heart Journal|May 19, 2016
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trialMichael Haude, Hüseyin Ince, Alexandre Abizaid, et al.
JACC. Cardiovascular Interventions|October 9, 2020
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes MellitusGjin Ndrepepa, Adnan Kastrati, Maurizio Menichelli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 14, 2011
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registryFlorim Cuculi, Adrian P Banning, Alexander Abizaid, et al.
JACC. Cardiovascular Interventions|October 25, 2014
Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot studyJosep Rodés-Cabau, Philip Kahlert, Franz-Josef Neumann, et al.
Coronary Artery Disease|February 1, 2022
Prediction of risk for bleeding, myocardial infarction and mortality after percutaneous coronary intervention in patients with acute coronary syndromesGjin Ndrepepa, Franz-Josef Neumann, Maurizio Menichelli, et al.
Journal of the American College of Cardiology|May 5, 2018
Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft LesionsRoisin Colleran, Sebastian Kufner, Julinda Mehilli, et al.
Circulation Research|June 23, 2018
The Transcription Factor ETV1 Induces Atrial Remodeling and ArrhythmiaCarolin Rommel, Stephan Rösner, Achim Lother, et al.
Journal of the American College of Cardiology|October 18, 2003
A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein graftsVolker Schächinger, Christian W Hamm, Thomas Münzel, et al.
Pageof 48